How active are patients with heart failure and implantable cardioverter-defibrillator - a pilot study

被引：0
|
作者：
Kisko, A. [1 ]
Dernarova, L. [2 ]
Kmec, J. [3 ]
Hudakova, A. [2 ]
Jakubikova, M. [2 ]
Santova, T. [2 ]
Magurova, D. [2 ]
Sulicova, A. [2 ]
Mroskova, M. [2 ]
机构：
[1] Reiman Univ Hosp, Sekcov Polyclin, Cardiol Clin, Presov, Slovakia
[2] Univ Presov, Fac Hlth Care, Presov, Slovakia
[3] Reiman Univ Hosp, Cardiol Clin, Presov, Slovakia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2013年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [21] RISK FACTORS FOR APPROPRIATE CARDIOVERTER-DEFIBRILLATOR SHOCKS, INAPPROPRIATE CARDIOVERTER-DEFIBRILLATOR SHOCKS, AND MORTALITY IN 549 PATIENTS WITH HEART FAILURE AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
    Aronow, Wilbert S.
    Desai, Harit
    Gandhi, Kaushang
    Ahn, Chul
    Hussain, Sadaf
    Lai, Hoang M.
    Sharma, Mala
    Frishman, William H.
    Cohen, Martin
    Sorbera, Carmine
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [22] Selecting patients for an Implantable cardioverter-defibrillator
    Mittal, Suneet
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (03) : 297 - 299
  • [23] The implantable cardioverter-defibrillator
    Raj, SR
    Sheldon, RS
    PROGRESS IN CARDIOVASCULAR DISEASES, 2001, 44 (03) : 169 - 194
  • [24] Mortality among ischemic and nonischemic heart failure patients with a primary implantable cardioverter-defibrillator
    Yang, Pil-Sung
    Kang, Younghyun
    Bae, Han-Joon
    Sung, Jung-Hoon
    Park, Hyung-Deuk
    Joung, Boyoung
    JOURNAL OF ARRHYTHMIA, 2021, 37 (06) : 1537 - 1545
  • [25] Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
    Rorth, Rasmus
    Dewan, Pooja
    Kristensen, Soren Lund
    Jhund, Pardeep S.
    Petrie, Mark C.
    Kober, Lars
    McMurray, John J. V.
    CLINICAL RESEARCH IN CARDIOLOGY, 2019, 108 (08) : 868 - 877
  • [26] Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure
    Katsiyiannis, WT
    Waggoner, AD
    Barzilai, B
    Gage, BF
    Sanchez, JM
    Rogers, JG
    Lindsay, BD
    Gleva, MJ
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (02): : 286 - 288
  • [27] Genetic polymorphisms of the adrenergic system and implantable cardioverter-defibrillator therapies in patients with heart failure
    Chemello, Diego
    Rohde, Luis E.
    Santos, Katia G.
    Silvello, Daiane
    Goldraich, Livia
    Pimentel, Mauricio
    Rosa, Priscila R.
    Zimerman, Leandro
    Clausell, Nadine
    EUROPACE, 2010, 12 (05): : 686 - 691
  • [28] How to consider the indication of implantable cardioverter-defibrillator in the elderly patients
    Kataoka, Naoya
    Imamura, Teruhiko
    CLINICAL CARDIOLOGY, 2024, 47 (02)
  • [29] Gender difference in arrhythmia recurrences in patients with nonischemic heart failure and implantable cardioverter-defibrillator
    Takahashi, A.
    Shiga, T.
    Suzuki, G.
    Shoda, M.
    Hagiwara, N.
    Kasanuki, H.
    EUROPEAN HEART JOURNAL, 2007, 28 : 286 - 286
  • [30] Approach to reduction of ventricular arrhythmias and implantable cardioverter-defibrillator therapies in patients with heart failure
    Sengupta, Jay
    Abdelhadi, Raed
    CURRENT OPINION IN CARDIOLOGY, 2013, 28 (03) : 337 - 343
12345